Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial.

Joharchi, Khojasteh; Memari, Moosareza; Azargashb, Eznollah; Saadat, Navid

Joharchi, Khojasteh; Memari, Moosareza; Azargashb, Eznollah; Saadat, Navid.

Afiliación

Joharchi K; 1Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences (SBUMS), Tehran, Iran.
Memari M; 1Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences (SBUMS), Tehran, Iran.
Azargashb E; 2Department of Social Medicine, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saadat N; 3Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

J Diabetes Metab Disord ; 18(2): 575-582, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31890684

Palabras clave

Adverse drug reactions (ADRs); Diabetes; Diabetic peripheral neuropathic pain (DPNP); Duloxetine (DLX); Pregabalin (PGB)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Diabetes Metab Disord Año: 2019 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google